Participants 81 122 7
patients with early rheumatoid arthritis.
Participants 196 288 5
patients with early rheumatoid arthritis (RA) undergoing longterm treatment with etanercept.
Participants 297 523 7
Patients with early RA (disease duration of 3 years or less) who had completed a 2-year efficacy study comparing etanercept and methotrexate (MTX) were followed in an extension where they received 25 mg etanercept twice weekly
Participants 973 1053 3
Efficacy was sustained in patients who completed 5 years of etanercept treatment
Participants 1348 1373 4
in patients with early RA
Participants 1615 1698 3
in patients with early aggressive RA who undergo longterm treatment with etanercept
